Journal for ImmunoTherapy of Cancer (Nov 2021)
757 M9657, a novel tumor-targeted conditional anti-CD137 agonist displays MSLN-dependent anti-tumor immunity
- Jacques Moisan,
- Chunxiao Xu,
- Amit Deshpande,
- Joern-Peter Halle,
- Neil Brewis,
- Lindsay Webb,
- Brain Rabinovich,
- Xueyuan Zhou,
- Frederic Christian Pipp,
- Rene Schweickhardt,
- Sireesha Yalavarthi,
- Clotilde Bourin,
- Payel Ghatak,
- Barroq Safi,
- Francisca Wollerton,
- Jose Munoz-Olaya,
- Natalya Belousova,
- Marat Alimzhanov,
- Martina Hubensack,
- Andree Blaukat
Affiliations
- Jacques Moisan
- Aff1 grid.476494.cLycera Corp. Ann Arbor MI USA
- Chunxiao Xu
- Aff167 grid.467308.e0000000404126436EMD Serono Belmont MA USA
- Amit Deshpande
- Cardiovascular Radiology and Endovascular Interventions, All India Institute of Medical Sciences, New Delhi, Delhi, India
- Joern-Peter Halle
- Aff18 0000 0004 0370 7685grid.34474.30EMD Serono Research and Development Belmont MA USA
- Neil Brewis
- F-Star Biotechnology Ltd, Cambrige, UK
- Lindsay Webb
- TCR2 Therapeutics, Cambridge, MA, USA
- Brain Rabinovich
- 1EMD Serono Research and Development Institute, Belmont, MA, United States
- Xueyuan Zhou
- 1EMD Serono Research and Development Institute, Belmont, MA, United States
- Frederic Christian Pipp
- 2The Healthcare Business of Merck KGaA, Billerica, MA, United States
- Rene Schweickhardt
- 3EMD Serono Research and Development Inst, Billerica, MA, United States
- Sireesha Yalavarthi
- 1EMD Serono Research and Development Institute, Belmont, MA, United States
- Clotilde Bourin
- 1EMD Serono Research and Development Institute, Belmont, MA, United States
- Payel Ghatak
- 3EMD Serono Research and Development Inst, Billerica, MA, United States
- Barroq Safi
- 1EMD Serono Research and Development Institute, Belmont, MA, United States
- Francisca Wollerton
- 4F-star Therapeutics, Cambridge, United Kingdom
- Jose Munoz-Olaya
- 4F-star Therapeutics, Cambridge, United Kingdom
- Natalya Belousova
- 1EMD Serono Research and Development Institute, Belmont, MA, United States
- Marat Alimzhanov
- 1EMD Serono Research and Development Institute, Belmont, MA, United States
- Martina Hubensack
- 2The Healthcare Business of Merck KGaA, Billerica, MA, United States
- Andree Blaukat
- 2The Healthcare Business of Merck KGaA, Billerica, MA, United States
- DOI
- https://doi.org/10.1136/jitc-2021-SITC2021.757
- Journal volume & issue
-
Vol. 9,
no. Suppl 2
Abstract
No abstracts available.
